Genestra brand AFA-gen capsule 15 mg Niacin/ capsule 300 mg Blue Green Algae / capsule 2…
Recalling firm: Seroyal International, a division of Atrium Innovations
Microcystins level found to be above the specification limit of NMT1 ppm as per Raw Material Specification.
Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Nov 25, 2020.
Check your package
Compare the exact product and package details with the label you have.
FDA code information
Lot # 6E436-0; Product Code # 07596; Expiry Date: 09/2018
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
Genestra brand AFA-gen capsule 15 mg Niacin/ capsule 300 mg Blue Green Algae / capsule 2 capsules, twice daily Dietary supplement 90 capsules, White 150cc HDPE Bottle with Desiccant and white cap, packed as 12 bottles / shipper case
Extracted codes and context
| Type | Code / value | Context |
|---|---|---|
| lot | 6E436-0 | Lot # 6E436-0; Product Code # 07596; Expiry Date: 09/2018 |
Original FDA recall reason
Microcystins level found to be above the specification limit of NMT1 ppm as per Raw Material Specification.
Recall details
- Recall number
- F-1756-2018
- Event ID
- 80661
- FDA status
- Terminated
- Initiated
- Jul 27, 2018
- Reported
- Aug 15, 2018
- Classified
- Aug 6, 2018
- Terminated
- Nov 25, 2020
- Quantity
- 4,226 bottles (1691 Canada and 2535 USA)
- Location
- Richmond Hill, Ontario, Canada
- Initiation type
- Voluntary: Firm initiated
- Notification
- Letter
Where it was distributed
Product was distributed throughout the United States and Canada (see attached document for list of Canadian consignees).
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.